CLLS Cellectis SA ADRs

Cellectis SA is a gene-editing company, employing its core proprietary technologies to develop products in the emerging field of immuno-oncology. Its two segment includes Therapeutics and Plants. This is an ADR of a company whose stock trades outside of the U.S. as the symbol FP:ALCLS.

$22.71  +1.21 (5.63%)
As of 03/01/2021 15:59:07 EST     IEX book   CBOE book


Security Information
Category1:
Category2:
Category3:
GICS sector:
Industry:
Index country:
Country of incorporation:
IPO date:
Outstanding shares:
Average volume:
Market cap:
Current dividend yield:
All SEC filings:
Annual filings:
CUSIP:
ISIN:
Sedol:
US Equity
ADRs
Small cap
Health Care
Biotechnology
France
France
03/25/2015
42,486,133
511,654
$913,451,860
0.00%
SEC Edgar Online
20-F
15117K103
US15117K1034
BWFKZT2

Valuation   (See tab for details)
PE ratio:
PB ratio:
PS ratio:
Return on equity:
Net income %:
-11.42
3.14
36.05
-27.19%
-311.63%

2021 © Stock Market MBA, Inc. Terms of use | Privacy policy